🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05843487
Active, not recruiting Observational

Association Between Carotid Plaque Length and Cardiovascular Outcomes

NCT05843487 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Observational
Started
2017-01-01
Last updated
2023-05-06

Condition(s) studied

Coronary Artery DiseaseCarotid Plaque

Study summary

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 5000 consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization from January 2017 through December 2018.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients who underwent coronary angiography for stable chest pain and carotid ultrasound simultaneously; * Patients with obstructive CAD (≥50% coronary stenosis); Exclusion Criteria: * \<18 years of age; * previous carotid surgery or significant carotid artery disease; * prior stroke or transient ischemic attack; * previously documented CAD (including history of myocardial infarction, acute coronary syndrome, or coronary revascularization);

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi Jiangsu
Changhai Hospital Shanghai Shanghai Municipality
Gongli Hospital Shanghai Shanghai Municipality
Putuo Hospital Shanghai Shanghai Municipality
Yueyang Hospital Shanghai Shanghai Municipality

More Changhai Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05843487 on ClinicalTrials.gov ↗ ← All trials in China